From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?

• Hauptverfasser: Amir Hashemi-Meshkini (Verfasst von), Mehdi Varmaghani (Verfasst von), Mehdi Yousefi (Verfasst von), Saeed Yaghoubifard (Verfasst von), Hedieh-Sadat Zekri (Verfasst von), Shekoufeh Nikfar (Verfasst von), Abbas Kebriaeezadeh (Verfasst von)
• Format: Buch
• Veröffentlicht: Wolters Kluwer Medknow Publications, 2014-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Objective: Brand-generic scheme was implemented in Iran to improve the competition in the pharmaceutical market. In this study, we aim to assess if this policy had any positive effect on efficiency of Iranian pharmaceutical companies. Methods: We used data envelopment analysis to evaluate the relati...